H-ASMTNMELM-OH

Ref. 3D-PP44308

Informations sur le produit

• Nom: H-ASMTNMELM-OH
• Synonymes: NH2-Ala-Ser-Met-Thr-Asn-Met-Glu-Leu-Met-OH

Description

Peptide H-ASMTNMELM-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-ASMTNMELM-OH include the following: Myeloid Cell-Triggered in Situ Cell Engineering for Robust Vaccine-Based Cancer Treatment WH Li, JY Su, BD Zhang, L Zhao, SH Zhuo - Advanced , 2024 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/adma.202308155 Effective neoantigen vaccination correlates with generation of antigen-specific CX3CR1+CD8+ T cells mediated by CD40 and CD80/86 signaling in cDC1s T Yamauchi , T Hoki , T Oba , X Cao, F Ito - bioRxiv, 2020 - biorxiv.orghttps://www.biorxiv.org/content/10.1101/2020.06.15.151787.abstract CD40 and CD80/86 signaling in cDC1s mediate effective neoantigen vaccination and generation of antigen-specific CX3CR1+ CD8+ T cells T Yamauchi , T Hoki , T Oba , R Kajihara - Cancer Immunology , 2022 - Springerhttps://link.springer.com/article/10.1007/s00262-021-02969-6 Responsive multivesicular polymeric nanovaccines that codeliver STING agonists and neoantigens for combination tumor immunotherapy T Su, F Cheng, J Qi, Y Zhang, S Zhou , L Mei - Advanced , 2022 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/advs.202201895 Designer vaccine nanodiscs for personalized cancer immunotherapy R Kuai , LJ Ochyl , KS Bahjat , A Schwendeman - Nature materials, 2017 - nature.comhttps://www.nature.com/articles/nmat4822 A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer Q Ni , F Zhang , Y Liu , Z Wang , G Yu , B Liang, G Niu - Science , 2020 - science.orghttps://www.science.org/doi/abs/10.1126/sciadv.aaw6071 Non-covalent glycosylated gold nanoparticles/peptides nanovaccine as potential cancer vaccines L Zeng, Z Liao, W Li, Q Yuan , P Wu, Z Gu , Z Liu - Chinese Chemical , 2020 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1001841719306199 Rapalog combined with CCR4 antagonist improves anticancer vaccines efficacy L Beziaud, L Boullerot, T Tran, L Mansi - Journal of Cancer, 2018 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.31842 Personalized combination nano-immunotherapy for robust induction and tumor infiltration of CD8+ T cells KS Park , J Nam , S Son , JJ Moon - Biomaterials, 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0142961221002003 Molecular retargeting of antibodies converts immune defense against oncolytic viruses into cancer immunotherapy J Niemann, N Woller, J Brooks - Nature , 2019 - nature.comhttps://www.nature.com/articles/s41467-019-11137-5 A Universal Cyclodextrin-Based Nanovaccine Platform Delivers Epitope Peptides for Enhanced Antitumor Immunity J Mao, Z Jin, X Rui, L Li, C Hou, X Leng - Advanced , 2023 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/adhm.202301099 Discovering tumor-reactive T-cell receptors through single-cell sequencing of tumor-infiltrating lymphocytes E Gottschalk, BA Aksoy , P Aksoy , M Swiderska-syn - bioRxiv, 2021 - biorxiv.orghttps://www.biorxiv.org/content/10.1101/2021.11.30.470597.abstract Co-Delivery of Peptide Neoantigens and Stimulator of Interferon Genes (STING) Agonists Enhances Response to Cancer Vaccines D Shae , JJ Baljon , M Wehbe , PP Christov, KW Becker - academia.eduhttps://www.academia.edu/download/89775167/pdf.pdf Co-delivery of peptide neoantigens and stimulator of interferon genes agonists enhances response to cancer vaccines D Shae , JJ Baljon , M Wehbe , PP Christov, KW Becker - ACS , 2020 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsnano.0c02765 Positron emission tomography-guided photodynamic therapy with biodegradable mesoporous silica nanoparticles for personalized cancer immunotherapy C Xu , J Nam , H Hong , Y Xu, JJ Moon - ACS nano, 2019 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsnano.9b06691 Identification of a neo-epitope dominating endogenous CD8 T cell responses to MC-38 colorectal cancer C van den Ende, D Ruano, K Franken, GMC Janssen - 2019 - academia.eduhttps://www.academia.edu/download/73699300/2162402X.2019.pdf Identification of a neo-epitope dominating endogenous CD8 T cell responses to MC-38 colorectal cancer BJ Hos, MGM Camps, J Bulk , E Tondini - , 2020 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/2162402X.2019.1673125 Bulk,. an den B Hos, MGM Camps - , E., Ende, TC , 2020 - scholarlypublications https://scholarlypublications.universiteitleiden.nl/access/item%3A3221192/download Cancer immunotherapy with immunomodulatory anti-CD137 and anti-PD-1 monoclonal antibodies requires BATF3-dependent dendritic cells AR Sanchez-Paulete , FJ Cueto , M Martaca­nez-Lopez - Cancer discovery, 2016 - AACRhttps://aacrjournals.org/cancerdiscovery/article-abstract/6/1/71/5336

• Marque: Biosynth